I would expect the conversation to go more like th
Post# of 148170
MHRA:. Thank you for your submission, the purpose of this meeting is to give you the information you need to quickly obtain approval in the UK. We are impressed with your CD10 results, as well as the EIND. We very much look forward to the CD12 data as well. With that said we want to start the process of approving Leronlimab now.
CYDY:. Great. So, uh. What do we do?
MHRA:. Here are the steps:
(Insert steps)